{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:53:15Z","timestamp":1787053995665,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010018","name":"Doctoral Start-up Foundation of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.peptides.2020.170375","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T20:57:50Z","timestamp":1596747470000},"page":"170375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Liraglutide ameliorates lipotoxicity-induced inflammation through the mTORC1 signalling pathway"],"prefix":"10.1016","volume":"133","author":[{"given":"Na","family":"Ao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enjie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2020.170375_bib0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1517\/14728222.2016.1096930","article-title":"Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease","volume":"20","author":"Sun","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.peptides.2020.170375_bib0010","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.peptides.2020.170375_bib0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.peptides.2020.170375_bib0020","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1111\/jcmm.13636","article-title":"The TLR4-IRE1\u03b1 pathway activation contributes to palmitate-elicited lipotoxicity in hepatocytes","volume":"22","author":"Shen","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.peptides.2020.170375_bib0025","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1073\/pnas.1716173114","article-title":"Twenty-five years of mTOR: uncovering the link from nutrients to growth","volume":"114","author":"Sabatini","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.peptides.2020.170375_bib0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7150\/ijbs.14027","article-title":"Dysregulation of the low-density lipoprotein receptor pathway is involved in lipid disorder-mediated organ injury","volume":"12","author":"Zhang","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.peptides.2020.170375_bib0035","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cmet.2012.03.015","article-title":"Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c","volume":"15","author":"Hagiwara","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.peptides.2020.170375_bib0040","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.celrep.2015.07.016","article-title":"A positive feedback loop between akt and mTORC2 via SIN1 phosphorylation","volume":"12","author":"Yang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.peptides.2020.170375_bib0045","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/onc.2017.360","article-title":"mTORC2\/AKT\/HSF1\/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma","volume":"37","author":"Holmes","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.peptides.2020.170375_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-981-10-8684-7_5","article-title":"NAFLD Related-HCC: The Relationship with Metabolic Disorders","volume":"1061","author":"Zhang","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.peptides.2020.170375_bib0055","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3748\/wjg.v25.i12.1492","article-title":"Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT\/mTOR\/SREBP-1 signaling pathway","volume":"25","author":"Hu","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.peptides.2020.170375_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4825949","article-title":"Cherry anthocyanins regulate NAFLD by promoting autophagy pathway","volume":"2019","author":"Chu","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.peptides.2020.170375_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051223","article-title":"Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks","volume":"20","author":"Hardeland","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.peptides.2020.170375_bib0070","doi-asserted-by":"crossref","unstructured":"K. Ding, H. Wang, J. Xu, X. Lu, L. Zhang, L. Zhu, Melatonin reduced microglial activation and alleviated neuroinflammation induced neuron degeneration in experimental traumatic brain injury: Possible involvement of mTOR pathway, Neurochem. Int. 76 (2014) 23-31.","DOI":"10.1016\/j.neuint.2014.06.015"},{"key":"10.1016\/j.peptides.2020.170375_bib0075","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3389\/fphar.2018.01168","article-title":"GLP-1 improves adipocyte insulin sensitivity following induction of endoplasmic reticulum stress","volume":"9","author":"Jiang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.peptides.2020.170375_bib0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbrc.2016.05.086","article-title":"GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK\/mTOR pathway","volume":"476","author":"He","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2020.170375_bib0085","first-page":"3573","article-title":"Glucagon-like peptide-1 modulates RAW264.7 macrophage polarization by interfering with the JNK\/STAT3 signaling pathway","volume":"17","author":"Wan","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.peptides.2020.170375_bib0090","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/oby.2011.50","article-title":"Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats","volume":"19","author":"Hayes","year":"2011","journal-title":"Obesity Silver Spring (Silver Spring)"},{"key":"10.1016\/j.peptides.2020.170375_bib0095","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bcpt.13082","article-title":"Liraglutide decreases hepatic inflammation and injury in advanced lean non-alcoholic steatohepatitis","volume":"123","author":"Ipsen","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.peptides.2020.170375_bib0100","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.13330","article-title":"Inhibition of microRNA-124a attenuates non-alcoholic fatty liver disease through upregulation of adipose triglyceride lipase and the effect of liraglutide intervention","author":"Fang","year":"2019","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.peptides.2020.170375_bib0105","doi-asserted-by":"crossref","unstructured":"N. Ao, J. Yang, X. Wang, Du J., Glucagon-like peptide-1 preserves non-alcoholic fatty liver disease through inhibition of the endoplasmic reticulum stress-associated pathway, Hepatol. Res. 46 (2016) 343-353.","DOI":"10.1111\/hepr.12551"},{"key":"10.1016\/j.peptides.2020.170375_bib0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cbi.2018.01.004","article-title":"Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition","volume":"282","author":"Patel","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.peptides.2020.170375_bib0115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fendo.2018.00649","article-title":"Future perspectives on GLP-1 receptor agonists and GLP-1\/glucagon receptor Co-agonists in the treatment of NAFLD","volume":"9","author":"Seghieri","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.peptides.2020.170375_bib0120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/ijms17040450","article-title":"Nutritional signaling via free fatty acid receptors","volume":"17","author":"Miyamoto","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.peptides.2020.170375_bib0125","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1210\/jc.2017-00047","article-title":"How to measure adipose tissue insulin sensitivity","volume":"102","author":"S\u00f8ndergaard","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.peptides.2020.170375_bib0130","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1136\/gutjnl-2017-313778","article-title":"Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase\/hydrogen sulfide pathway","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.peptides.2020.170375_bib0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000480367","article-title":"Autophagy inhibition contributes to ROS-Producing NLRP3-Dependent inflammasome activation and cytokine secretion in high glucose-induced macrophages","volume":"43","author":"Dai","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.peptides.2020.170375_bib0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41467-017-00213-3","article-title":"Hypoxia ameliorates intestinal inflammation through NLRP3\/mTOR downregulation and autophagy activation","volume":"8","author":"Cosin-Roger","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.peptides.2020.170375_bib0145","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/abbs\/gmy088","article-title":"mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus, Acta Biochim","volume":"50","author":"Li","year":"2018","journal-title":"Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.peptides.2020.170375_bib0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biocel.2015.01.011","article-title":"Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver disease","volume":"61","author":"Liu","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.peptides.2020.170375_bib0155","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1182\/blood-2010-09-310888","article-title":"Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells","volume":"117","author":"Weichhart","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.peptides.2020.170375_bib0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brainres.2019.01.005","article-title":"Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI","volume":"1710","author":"Chen","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2020.170375_bib0165","doi-asserted-by":"crossref","DOI":"10.1002\/stem.3036","article-title":"Inhibition of mTOR by rapamycin aggravates corneal epithelial stem cell deficiency by upregulating inflammatory response","author":"Park","year":"2019","journal-title":"Stem Cells"},{"key":"10.1016\/j.peptides.2020.170375_bib0170","doi-asserted-by":"crossref","unstructured":"M.J. Armstrong, D. Hull, K. Guo, D. Barton, J.M. Hazlehurst, L.L. Gathercole, et al., Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis, J. Hepatol. 64 (2016) 399-408.","DOI":"10.1016\/j.jhep.2015.08.038"},{"key":"10.1016\/j.peptides.2020.170375_bib0175","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/diabetes.51.2.424","article-title":"Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes","volume":"51","author":"Juhl","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.peptides.2020.170375_bib0180","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2020.170375_bib0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2017.05.015","article-title":"Liraglutide, a glucagon-like peptide-1 analog, induce autophagy and senescence in HepG2 cells","volume":"809","author":"Krause","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2020.170375_bib0190","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/hepr.12634","article-title":"Liraglutide ameliorates non-alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1\/SIRT3-FOXO3a pathway","volume":"46","author":"Tong","year":"2016","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.peptides.2020.170375_bib0195","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/jcb.24763","article-title":"Protective action of liraglutide in beta cells under lipotoxic stress via PI3K\/Akt\/FoxO1 pathway","volume":"115","author":"Shao","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.peptides.2020.170375_bib0200","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3892\/ijmm.2017.2910","article-title":"Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet \u03b2 cells via the activation of PDX-1\/JAK signaling transduction in C57\/BL6 mice with high-fat diet-induced diabetes","volume":"39","author":"Hao","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.peptides.2020.170375_bib0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.aohep.2019.06.023","article-title":"The preventive effect of liraglutide on the lipotoxic liver injury via increasing autophagy","volume":"19","author":"He","year":"2020","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.peptides.2020.170375_bib0210","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/cbin.11015","article-title":"Rapamycin improves insulin resistance and hepatic steatosis in type 2 diabetes rats through activation of autophagy","volume":"42","author":"Zhou","year":"2018","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.peptides.2020.170375_bib0215","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fendo.2018.00539","article-title":"The antidiabetic drug lobeglitazone protects mice from lipogenesis-induced liver injury via mechanistic target of rapamycin complex 1 inhibition","volume":"9","author":"Lee","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.peptides.2020.170375_bib0220","first-page":"2977","article-title":"GLP\u20111R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK\/NF\u2011\u03baB signaling pathways in streptozotocin\u2011induced diabetic rats","volume":"41","author":"Ma","year":"2018","journal-title":"Int. J. Mol. Med."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120301248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120301248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:26:28Z","timestamp":1759310788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978120301248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":44,"alternative-id":["S0196978120301248"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170375","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liraglutide ameliorates lipotoxicity-induced inflammation through the mTORC1 signalling pathway","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170375"}}